These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear: will cytologic screening for adenocarcinoma in situ reduce incidence rates for adenocarcinoma. Smith HO, Padilla LA. Cancer; 2002 Dec 25; 96(6):319-22. PubMed ID: 12478677 [No Abstract] [Full Text] [Related]
33. The progression of pre-invasive lesions of the cervix to invasion. Green GH. N Z Med J; 1974 Oct 09; 80(525):279-87. PubMed ID: 4531563 [No Abstract] [Full Text] [Related]
34. Evaluation of two simultaneously obtained cervical cytological smears. Sedlis A, Walters AT, Balin H, Hontz A, Lo Sciuto L. Acta Cytol; 1974 Oct 09; 18(4):291-6. PubMed ID: 4526248 [No Abstract] [Full Text] [Related]
35. The value of cytodiagnosis in cervix cancer precursors and the latency and progression of carcinoma in situ. Möbius G. Pathol Res Pract; 1985 Dec 09; 180(6):670-4. PubMed ID: 3832001 [Abstract] [Full Text] [Related]
38. Squamous cell carcinoma of the uterine cervix. A clinicopathologic study of 44 cases. Czernobilsky B, Rotenstreich L, Lancet M. Isr J Med Sci; 1972 Dec 09; 8(12):1944-52. PubMed ID: 4655310 [No Abstract] [Full Text] [Related]
39. [Examination for the prevention of gynecologic cancer in young women: when should cancer prevention begin?]. Heinzl S, Jochum L, Szalmay G, Roemer VM. Schweiz Med Wochenschr; 1981 Aug 22; 111(34):1249-52. PubMed ID: 7280634 [Abstract] [Full Text] [Related]